The IDE will enable EndoQuest to begin its Prospective Assessment of a Robotic-Assisted Device in Gastrointestinal Medicine (PARADIGM) study. This is a prospective, multi-center, open-label study of ...

EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal ...

The latest data contains key information for people with a long-term illness, disability, mental or physical health condition considering making a new claim for the additional financial support, worth ...

Cancer diagnoses during pregnancy and in the year following the birth are rare. But such cases are becoming more common in ...

In a pair of recently released reports, the Department of Defense Inspector General’s Office offered a scathing assessment of ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Among the common but lesser-known consequences of intimate partner violence is a heightened risk for cardiovascular disease.

Stryker (NYSE:SYK) today announced the launch of the next generation of SurgiCount+ within its sponge management portfolio.

About EndoQuest Robotics EndoQuest Robotics is a leading innovator in the development of transformative endoluminal robotic ...

Three Chinese solar companies were found to have evaded taxes on approximately INR220 billion (US$2.64 billion) of profits ...

Many leaders say gastroenterology is getting hit harder by reimbursement cuts and payer behavior than other specialties. Several leaders joined Becker's Nov. 1 on a panel at the 30th annual Business ...

The assessment found a need for a large-scale cohort study ... with many papers stating evidence for and against certain ...